Anaplastic large-cell lymphoma the breast is a rare malignant condition and has been identified as a possible adverse effect of breast implants. In a research letter published by Kinslow et al in JAMA Oncology, study authors aimed to quantify the incidence of anaplastic large-cell lymphoma of the breast in the United States from 2000 to 2018.
